These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 26373473)

  • 21. Largely overlapping neuronal substrates of reactivity to drug, gambling, food and sexual cues: A comprehensive meta-analysis.
    Noori HR; Cosa Linan A; Spanagel R
    Eur Neuropsychopharmacol; 2016 Sep; 26(9):1419-1430. PubMed ID: 27397863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic mechanisms associated with addiction-related behavioural effects of nicotine and/or cocaine: implication of the endocannabinoid system.
    Hayase T
    Behav Pharmacol; 2017 Oct; 28(7):493-511. PubMed ID: 28704272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.
    Koob GF
    Psychopharmacology (Berl); 2017 May; 234(9-10):1315-1332. PubMed ID: 28050629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transitionality in addiction: A "temporal continuum" hypotheses involving the aberrant motivation, the hedonic dysregulation, and the aberrant learning.
    Patrono E; Gasbarri A; Tomaz C; Nishijo H
    Med Hypotheses; 2016 Aug; 93():62-70. PubMed ID: 27372858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time to connect: bringing social context into addiction neuroscience.
    Heilig M; Epstein DH; Nader MA; Shaham Y
    Nat Rev Neurosci; 2016 Sep; 17(9):592-9. PubMed ID: 27277868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influences of social reward experience on behavioral responses to drugs of abuse: Review of shared and divergent neural plasticity mechanisms for sexual reward and drugs of abuse.
    Beloate LN; Coolen LM
    Neurosci Biobehav Rev; 2017 Dec; 83():356-372. PubMed ID: 29108963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alcohol-Endocannabinoid Interactions: Implications for Addiction-Related Behavioral Processes.
    Serrano A; Natividad LA
    Alcohol Res; 2022; 42(1):09. PubMed ID: 35655710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocannabinoid and dopaminergic system: the pas de deux underlying human motivation and behaviors.
    Laksmidewi AAAP; Soejitno A
    J Neural Transm (Vienna); 2021 May; 128(5):615-630. PubMed ID: 33712975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocannabinoid-mediated synaptic plasticity and substance use disorders.
    Fernández-Espejo E; Núñez-Domínguez L
    Neurologia (Engl Ed); 2022; 37(6):459-465. PubMed ID: 30857785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of the endocannabinoid system in reward processing in the human brain.
    van Hell HH; Jager G; Bossong MG; Brouwer A; Jansma JM; Zuurman L; van Gerven J; Kahn RS; Ramsey NF
    Psychopharmacology (Berl); 2012 Feb; 219(4):981-90. PubMed ID: 21822593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurobiology and systems physiology of the endocannabinoid system.
    Wegener N; Koch M
    Pharmacopsychiatry; 2009 May; 42 Suppl 1():S79-86. PubMed ID: 19434559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives.
    Scherma M; Muntoni AL; Melis M; Fattore L; Fadda P; Fratta W; Pistis M
    Psychopharmacology (Berl); 2016 May; 233(10):1765-77. PubMed ID: 26728894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function.
    Hariri AR; Gorka A; Hyde LW; Kimak M; Halder I; Ducci F; Ferrell RE; Goldman D; Manuck SB
    Biol Psychiatry; 2009 Jul; 66(1):9-16. PubMed ID: 19103437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The endocannabinoid system: emotion, learning and addiction.
    Moreira FA; Lutz B
    Addict Biol; 2008 Jun; 13(2):196-212. PubMed ID: 18422832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An endocannabinoid hypothesis of drug reward and drug addiction.
    Onaivi ES
    Ann N Y Acad Sci; 2008 Oct; 1139():412-21. PubMed ID: 18991888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Addiction-induced plasticity in underlying neural circuits.
    Kourosh-Arami M; Komaki A; Gholami M
    Neurol Sci; 2022 Mar; 43(3):1605-1615. PubMed ID: 35064341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The contribution of brain reward circuits to the obesity epidemic.
    Stice E; Figlewicz DP; Gosnell BA; Levine AS; Pratt WE
    Neurosci Biobehav Rev; 2013 Nov; 37(9 Pt A):2047-58. PubMed ID: 23237885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DAGL-dependent endocannabinoid signalling: roles in axonal pathfinding, synaptic plasticity and adult neurogenesis.
    Oudin MJ; Hobbs C; Doherty P
    Eur J Neurosci; 2011 Nov; 34(10):1634-46. PubMed ID: 22103420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The endogenous cannabinoid system and drug addiction: 20 years after the discovery of the CB1 receptor.
    de Fonseca FR; Schneider M
    Addict Biol; 2008 Jun; 13(2):143-6. PubMed ID: 18482429
    [No Abstract]   [Full Text] [Related]  

  • 40. The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction.
    López-Moreno JA; González-Cuevas G; Moreno G; Navarro M
    Addict Biol; 2008 Jun; 13(2):160-87. PubMed ID: 18422831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.